100
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Comparison of iohexol and lactulose-mannitol tests as markers of disease activity in patients with inflammatory bowel disease

Pages 695-701 | Published online: 08 Jul 2009

REFERENCES

  • Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992; 27: 721–6.
  • Bjarnason I, MacPherson A, Hollander D. Intest-inal permeablity: an overview. Gastroenterology 1995; 108: 1566–81.
  • Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S, Pedreira S, Boerr L, Maurino E, Meddings JB. Gastrointestinal perme-ability in celiac disease. Gastroenterology 1997; 112: 1129–36.
  • Jalonen T, Isolauri E, Heyman M, Crain-Denoyelle AM, Sillanaukee P, Koivula T. Increased beta-lactoglobulin absorption during rotavirus enteritis in infant: relationship to sugar permeability. Pediatr Res 1991; 30: 290–3.
  • de Maar EE, Kleibeuker JH, Boerma-van Ek W, The TH, van Son WJ. Increased intestinal permeability during cytomegalovirus infection in renal transplanat recipients. Transpl Int. 1996; 9: 576–80.
  • Söderholm JD, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, Järnerot G, Sjödahl R. Different intestinal permeability pattern in rela-tives and spouses of patients with Crohn's disease: an inhereted defect in mucosal defence? Gut 1999; 44: 96–100.
  • Peeters M, Geypens B, Claus D, Nevens H, Ghooa Y, Verbeke G, Baert F, Vermeire S. Vlietinck, Rutgeerts P. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997; 113: 802–7.
  • Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz KD, Binder V. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994; 35: 68–72.
  • May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993; 104: 1627–32.
  • Wyatt J, Vogelsang H, Hübl W, Waldhoer T, Lochs H. Intestinal permeability and the predic-tion of relapse in Crohn's disease. Lancet 1993; 341: 1437–9.
  • Blomquist L, Bark T, Hedenborg G, Norman A. Evaluation of the lactulose/mannitol and 51Cr-Ethylenediaminetetraaceticacid/14C-mannitolmethods for intestinal permeability. Scand J Gastroenterol 1997; 32: 805–12.
  • Halme L, Edgren J, von Smitten K, Linden H. Increased urinary excretion of iohexol after enteral administration on patients with ileal Crohn's disease—a new test for disease activity. Acta Radiol 1993; 34: 237–41.
  • Halme L, Edgren J, Turpeinen U, von Smitten K, Stenman U-H. Urinary excretion of iohexol as a marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroen-terol 1997; 32: 148–52.
  • Andersen R, Laerum F, Bay D, Aas K, Halstensen TS, Stordahl A. Experimental colonic inflamma-tion and ulceration, permeation of water-soluble contrast medium as a measure of "disease" activity. Scand J Gastroenterol 1992; 27: 757–63.
  • Myren J, Bouchier IA, Watkinson G, Softley A, Clamp SE, de Bombal FT. The OMGE multi-national inflammatory bowel disease survey 1976–1982. A further report of 2657 cases. Scand J Gastroenterol 1984; 23 Suppl. 95: 1–27.
  • Truelove SC, Witts U. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 2: 1041–8.
  • Turpeinen U, Pomoell UM. Liquid chromato-graphic determination of meglumine diatrizoate in human plasma and urine. J Chromatogr 1986; 377: 460–5.
  • Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986; 91: 1490–4.
  • Mary JY, Modigliani R. Development and validation of a Crohn's disease endoscopic index of severity: a prospective multicentric study. Gut 1989; 30: 983–9.
  • D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C, Venturi C, Longo G, Strurniolo GC. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 1999; 94: 2956–60.
  • Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Scott D, Gumpel MJ, Bjamason I. Intestinal permeability and inflam-mation in patients on NSAIDs. Gut 1998; 43: 506— 11.
  • Hilsden RJ, Meddings JB, Sutherland LR. Intest-inal permeability changes in response to acetylsa-licylic acid in relatives of patients with Crohn's disease. Gastroenterology 1996; 110: 1395–403.
  • Riordan SM, Mciver CJ, Thomas DH, Duncombe VM, Bolin TD, Thomas MC. Luminal bacteria and small-intestinal permeability. Scand J Gastro-enterol 1997; 32: 556–63.
  • Akram S, Mourani S, Ou C, Rognerud C, Sadiq R, Goodgame RW. Assessment of intestinal permeablitiy with a two-hour urine collection. Dig Dis Sci 1998; 43: 1946–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.